Multicolour imaging in central serous chorioretinopathy.
Adult
Central Serous Chorioretinopathy
/ diagnosis
Choroid
/ diagnostic imaging
Female
Fluorescein Angiography
/ methods
Follow-Up Studies
Fundus Oculi
Humans
Male
Middle Aged
Reproducibility of Results
Retinal Pigment Epithelium
/ pathology
Retrospective Studies
Tomography, Optical Coherence
/ methods
Visual Acuity
central serous chorioretinopathy
imaging
multicolour
sensitivity
Journal
Clinical & experimental optometry
ISSN: 1444-0938
Titre abrégé: Clin Exp Optom
Pays: United States
ID NLM: 8703442
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
01
02
2019
revised:
29
07
2019
accepted:
30
07
2019
pubmed:
7
9
2019
medline:
9
6
2021
entrez:
7
9
2019
Statut:
ppublish
Résumé
Multicolour imaging (MI) is a novel, non-invasive retinal imaging technology. Its sensitivity for detecting the clinical features in central serous chorioretinopathy (CSCR) has not been previously described. The aim of this study is to evaluate the accuracy of MI compared to fluorescein angiography and colour fundus photography in CSCR, and to describe the imaging features of MI. In this retrospective study at a tertiary referral centre, 63 consecutive eyes with CSCR (both acute and chronic) were included after obtaining permission from the institutional review board. Multimodal imaging with colour fundus photography, optical coherence tomography, MI and fluorescein angiography/indocyanine green angiography and near-infrared and blue wavelength autofluorescence was analysed to identify the clinical findings in CSCR. Sensitivity and specificity values were computed for the different clinical features for each imaging modality. On comparison with fluorescein angiography, MI was found to be more effective in identifying the extent of subretinal fluid (78 per cent versus 13 per cent). MI was equally capable in identifying pigment epithelium detachment (100 per cent versus 100 per cent) and retinal pigment epithelial changes (100 per cent versus 100 per cent). Focal leaks were identified in 84 per cent and 97 per cent of eyes using MI and fluorescein angiography imaging, respectively. The sensitivity of MI in identifying focal retinal pigment epithelial leaks was higher compared to near-infrared autofluorescence (84 per cent versus 34 per cent) and blue wavelength autofluorescence (84 per cent versus 18 per cent) imaging. MI is a useful, non-invasive imaging modality for detecting clinical features in CSCR. In the future, MI has the potential to substitute for fluorescein angiography and colour fundus photography as the imaging modality of choice.
Sections du résumé
BACKGROUND
Multicolour imaging (MI) is a novel, non-invasive retinal imaging technology. Its sensitivity for detecting the clinical features in central serous chorioretinopathy (CSCR) has not been previously described. The aim of this study is to evaluate the accuracy of MI compared to fluorescein angiography and colour fundus photography in CSCR, and to describe the imaging features of MI.
METHODS
In this retrospective study at a tertiary referral centre, 63 consecutive eyes with CSCR (both acute and chronic) were included after obtaining permission from the institutional review board. Multimodal imaging with colour fundus photography, optical coherence tomography, MI and fluorescein angiography/indocyanine green angiography and near-infrared and blue wavelength autofluorescence was analysed to identify the clinical findings in CSCR. Sensitivity and specificity values were computed for the different clinical features for each imaging modality.
RESULTS
On comparison with fluorescein angiography, MI was found to be more effective in identifying the extent of subretinal fluid (78 per cent versus 13 per cent). MI was equally capable in identifying pigment epithelium detachment (100 per cent versus 100 per cent) and retinal pigment epithelial changes (100 per cent versus 100 per cent). Focal leaks were identified in 84 per cent and 97 per cent of eyes using MI and fluorescein angiography imaging, respectively. The sensitivity of MI in identifying focal retinal pigment epithelial leaks was higher compared to near-infrared autofluorescence (84 per cent versus 34 per cent) and blue wavelength autofluorescence (84 per cent versus 18 per cent) imaging.
CONCLUSION
MI is a useful, non-invasive imaging modality for detecting clinical features in CSCR. In the future, MI has the potential to substitute for fluorescein angiography and colour fundus photography as the imaging modality of choice.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-331Informations de copyright
© 2019 Optometry Australia.
Références
Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 63: 1-139.
Jalkh AE, Jabbour N, Avila MP et al. Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology 1984; 91: 1544-1548.
Yannuzzi LA, Shakin JL, Fisher YL et al. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984; 91: 1554-1572.
Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989; 96: 854-859.
Zhu X, Cheng Y, Pan X et al. Sensitivity and specificity of multispectral imaging in detecting central serous chorioretinopathy. Lasers Surg Med 2017; 49: 498-505.
Burumcek E, Mudun A, Karacorlu S et al. Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997; 104: 616-622.
Chan WM, Lam DS, Lai TY et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87: 1453-1458.
Yannuzzi LA, Slakter JS, Gross NE et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003; 23: 288-298.
Hee MR, Puliafito CA, Wong C et al. Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol 1995; 120: 65-74.
Lehmann M, Wolff B, Vasseur V et al. Retinal and choroidal changes observed with “En face” enhanced-depth imaging OCT in central serous chorioretinopathy. Br J Ophthalmol 2013; 97: 1181-1186.
Kim SK, Kim SW, Oh J et al. Near-infrared and short-wavelength autofluorescence in resolved central serous chorioretinopathy: association with outer retinal layer abnormalities. Am J Ophthalmol 2013; 156: 157-164.e2.
Sekiryu T, Iida T, Maruko I et al. Infrared fundus autofluorescence and central serous chorioretinopathy. Invest Ophthalmol Vis Sci 2010; 51: 4956-4962.
Tan AC, Fleckenstein M, Schmitz-Valckenberg S et al. Clinical Application of Multicolor Imaging Technology. Ophthalmologica 2016; 236: 8-18.
Ahmad MSZ, Carrim ZI. Multicolor Scanning Laser Imaging in Diabetic Retinopathy. Optom Vis Sci 2017; 94: 1058-1061.
Venkatesh R, Bavaharan B, Yadav NK et al. Multicolor imaging in choroidal osteomas. Int J Retina Vitreous 2018; 13: 46.
Song JH, Moon KY, Jang S et al. Comparison of MultiColor fundus imaging and colour fundus photography in the evaluation of epiretinal membrane. Acta Ophthalmol 2018; 97: e533-e539.
Keane PA, Sadda SR. Retinal imaging in the twenty-first century: state of the art and future directions. Ophthalmology 2014; 121: 2489-2500.
Manivannan A, Van der Hoek J, Vieira P et al. Clinical investigation of a true color scanning laser ophthalmoscope. Arch Ophthalmol 2001; 119: 819-824.